Furthermore, our results suggested that CADM1/TSLC1 negative expression was associated with shorter disease-free survival (DFS) and accordingly might predict early relapse of patients with ESCC after surgery. The gene discussed is CADM1; the disease is esophageal squamous cell carcinoma.